Skip to content

Real-world study of Xuanshen Yishen Decoction in the Treatment of Hypertension

Real-world study of Xuanshen Yishen Decoction in the Treatment of Hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086589
Enrollment
Unknown
Registered
2024-07-05
Start date
2024-07-06
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Treatment group (Administer the Xuanshen Yishen Decoction):None
Control group (The Xuanshen Yishen Decoction was not administered):None

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for hypertension (2) Age =40 years old, gender unlimited

Exclusion criteria

Exclusion criteria: (1) Secondary hypertension; (2) Malignant hypertension; (3) Patients with severe liver and kidney function injury and malignant tumor disease;

Design outcomes

Primary

MeasureTime frame
The attainment rate of intensive hypertension control: Systolic blood pressure = 120mmHg;

Secondary

MeasureTime frame
6-month all-cause readmission;

Countries

China

Contacts

Public ContactYun-Lun Li

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

1105381764@qq.com+86 178 6296 8375

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026